The article discusses a bacteria-based DNA-editing technique called clustered regularly interspaced short palindromic repeats (CRISPRs). Topics include the limitations of early genetic engineering methods, such as their lack of precision, research by Emmanuelle Charpentier, Jennifer Doudna, and colleagues who discovered how to use the Streptococcus bacterial protein Cas9 with an RNA guide in CRISPR technology, and SAGE Labs, which licenses Doudna's CRISPR technology for altering rodents.
© 2001-2024 Fundación Dialnet · Todos los derechos reservados